Welcome to LookChem.com Sign In|Join Free

CAS

  • or

927880-89-5

Post Buying Request

927880-89-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

927880-89-5 Usage

Chemical structure

A complex compound with multiple functional groups, including a benzene diamine core, a methyl group, a pyridinyl group, and a bulky N-methyl-4-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy] substituent.

Benzene diamine core

The central structure of the compound, consisting of a benzene ring with two amine (-NH2) groups attached.

Methyl group attachment

A methyl (-CH3) group is attached to the N1 position of the benzene diamine core.

Pyridinyl group

A heterocyclic compound with a nitrogen atom in a six-membered ring, linked to the compound.

Bulky substituent

A large N-methyl-4-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy] group that may influence the compound's properties and interactions.

Potential biological activity

The presence of various aromatic and heterocyclic moieties suggests that the compound may have interactions with biological targets, indicating possible pharmaceutical relevance.

Further research needed

To fully understand the properties, potential applications, and biological activity of this complex chemical, additional research and analysis are required.

Molecular weight

Approximately 369.32 g/mol (calculated from the chemical formula)

Appearance

The physical appearance of the compound is not provided, but it is likely a solid due to the presence of multiple aromatic and heterocyclic moieties.

Solubility

The solubility of the compound is not provided, but it may be soluble in organic solvents due to its lipophilic nature.

Stability

Information on the stability of the compound is not provided, but the presence of various functional groups may affect its stability under different conditions.

Reactivity

The reactivity of the compound is not provided, but the presence of amine, trifluoromethyl, and imidazol-2-yl groups may indicate potential reactivity with certain reagents or under specific conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 927880-89-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,7,8,8 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 927880-89:
(8*9)+(7*2)+(6*7)+(5*8)+(4*8)+(3*0)+(2*8)+(1*9)=225
225 % 10 = 5
So 927880-89-5 is a valid CAS Registry Number.

927880-89-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,2-Benzenediamine, N1-methyl-4-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-

1.2 Other means of identification

Product number -
Other names 1,2-BENZENEDIAMINE, N1-METHYL-4-[[2-[5-(TRIFLUOROMETHYL)-1H-IMIDAZOL-2-YL]-4-PYRIDINYL]OXY]-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:927880-89-5 SDS

927880-89-5Downstream Products

927880-89-5Relevant articles and documents

Discovery of RAF265: A Potent mut-B-RAF inhibitor for the treatment of metastatic melanoma

Williams, Teresa E.,Subramanian, Sharadha,Verhagen, Joelle,McBride, Christopher M.,Costales, Abran,Sung, Leonard,Antonios-Mccrea, William,McKenna, Maureen,Louie, Alicia K.,Ramurthy, Savithri,Levine, Barry,Shafer, Cynthia M.,MacHajewski, Timothy,Renhowe, Paul A.,Appleton, Brent A.,Amiri, Payman,Chou, James,Stuart, Darrin,Aardalen, Kimberly,Poon, Daniel

, p. 961 - 965 (2015/09/22)

Abrogation of errant signaling along the MAPK pathway through the inhibition of B-RAF kinase is a validated approach for the treatment of pathway-dependent cancers. We report the development of imidazo-benzimidazoles as potent B-RAF inhibitors. Robust in

SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF

-

, (2008/06/13)

Salts of benzimidazolyl pyridyl ethers are provided, particularly salts of { 1 -methyl-5- [2-(5-trifluoromethyl- 1 H-imidazol-2-yl)-pyridin-4-yloxy] - 1 H-benzoimidazol-2-yl } -(4- trifluoromethyl-phenyl)amine. Compositions and formulations including such

Substituted benzimidazoles and methods of preparation

-

Page/Page column 20, (2008/06/13)

Methods for preparing new substituted benzimidazole compounds having formula (I) useful for treating kinase mediated disorders are provided wherein R1, R2, R3, R4, a, b, and c are defined herein

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 927880-89-5